GLG Partners’s Mead Johnson Nutrition Company MJN Stock Holding History

GLG Partners’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-145,184	Closed	-$12.9M	–	506
2017 Q1	$12.9M	Buy	+145,184	New	+$11.9M	0.6%	49
2015 Q3	–	Sell	-19,909	Closed	-$1.8M	–	568
2015 Q2	$1.8M	Buy	+19,909	New	+$1.92M	0.05%	305

Other funds holding MJN

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

FNBOO

First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return

LFAS

Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

WEC

Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

GLG Partners's MJN Position: Q2 2017 in Review

GLG Partners sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 145,184 shares — an estimated $12.9M sold.

GLG Partners first reported a position in MJN in Q2 2015 and held it in 2 quarters. The position peaked at $12.9M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

GLG Partners reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
GLG Partners sold 145,184 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $12.9M.
GLG Partners first reported a position in Mead Johnson Nutrition Company in Q2 2015 and held it in 2 quarters.
GLG Partners's Mead Johnson Nutrition Company position peaked at $12.9M in Q1 2017.
7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on GLG Partners's 13F filing for Q2 2017, filed 14 Aug 2017.